Pantoprazole

Generic Name
Pantoprazole
Brand Names
Protonix, Somac Control, Tecta, Pantozol Control, Controloc Control
Drug Type
Small Molecule
Chemical Formula
C16H15F2N3O4S
CAS Number
102625-70-7
Unique Ingredient Identifier
D8TST4O562
Background

Pantoprazole is a first-generation proton pump inhibitor (PPI) used for the management of gastroesophageal reflux disease (GERD), for gastric protection to prevent recurrence of stomach ulcers or gastric damage from chronic use of NSAIDs, and for the treatment of pathological hypersecretory conditions including Zollinger-Ellison (ZE) Syndrome. It can also be...

Indication

Pantoprazole Injection:

Treatment of gastroesophageal reflux disease associated with a history of erosive esophagitis
...

Associated Conditions
Erosive Esophagitis, GERD With Erosive Esophagitis, Gastro-esophageal Reflux Disease (GERD), Healing, Heartburn, Helicobacter Pylori Infection, Stress Ulcers, Zollinger-Ellison Syndrome, Conditions where a reduction of gastric acid secretion is required, Pathological hypersecretory conditions
Associated Therapies
-
Clinical Trials
Related News

Symptomatic Relief of Acute Dyspeptic Pain in Emergency Department With Pantoprazole

First Posted Date
2011-01-24
Last Posted Date
2013-09-18
Lead Sponsor
Chulalongkorn University
Target Recruit Count
87
Registration Number
NCT01281501
Locations
🇹🇭

Emergency Medicine Unit, King Chulalongkorn Memorial Hospital, Patumwan, Bangkok, Thailand

Is Rebamipide Effective on the Healing of Iatrogenic Gastric Ulcer After Endoscopic Mucosal Resection?

Not Applicable
Completed
Conditions
Stomach Ulcer
Interventions
Drug: pantoprazole
Drug: Rebamipide
First Posted Date
2010-07-22
Last Posted Date
2015-09-04
Lead Sponsor
Kangdong Sacred Heart Hospital
Target Recruit Count
290
Registration Number
NCT01167101
Locations
🇰🇷

Kangdong Sacred Heart Hospital, Seoul, Korea, Republic of

Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Pantoprazole 80 mg in Healthy Subjects

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Clopidogrel
Drug: Placebo
Drug: Pantoprazole
First Posted Date
2010-05-24
Last Posted Date
2011-12-15
Lead Sponsor
Sanofi
Target Recruit Count
66
Registration Number
NCT01129427
Locations
🇺🇸

Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States

Clopidogrel Proton-Pump Inhibitors Study

Phase 4
Withdrawn
Conditions
Coronary Artery Disease
Interventions
Drug: Omeprazole
Drug: Pantoprazole
First Posted Date
2009-11-19
Last Posted Date
2016-10-21
Lead Sponsor
Sheba Medical Center
Registration Number
NCT01016717
Locations
🇮🇱

Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel

Drug-Drug Interaction of Cladribine and Pantoprazole in Multiple Sclerosis Subjects

Phase 1
Completed
Conditions
Multiple Sclerosis
Interventions
Drug: Cladribine
Drug: Pantoprazole
First Posted Date
2009-07-13
Last Posted Date
2016-04-14
Lead Sponsor
Merck KGaA, Darmstadt, Germany
Target Recruit Count
18
Registration Number
NCT00938366

Symptom Evaluation After Cessation of a Proton Pump Inhibitor in Healthy Volunteers

Not Applicable
Completed
Conditions
Healthy
Interventions
Drug: Pantoprazole
Drug: Placebo
First Posted Date
2009-06-05
Last Posted Date
2009-06-05
Lead Sponsor
Sahlgrenska University Hospital, Sweden
Target Recruit Count
50
Registration Number
NCT00915239
Locations
🇸🇪

Sahlgrenska Univeristy Hospital, Gothenburg, Sweden

Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding

Phase 4
Withdrawn
Conditions
Peptic Ulcer
Interventions
Drug: Pantoprazole
Drug: Esomeprazole
First Posted Date
2009-04-15
Last Posted Date
2015-04-08
Lead Sponsor
Lotung Poh-Ai Hospital
Registration Number
NCT00881413

Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)

Phase 3
Completed
Conditions
Gastroesophageal Reflux
Interventions
Drug: pantoprazole
First Posted Date
2009-03-24
Last Posted Date
2010-05-04
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Target Recruit Count
58
Registration Number
NCT00868296

Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori Eradication

First Posted Date
2009-02-11
Last Posted Date
2016-12-06
Lead Sponsor
Asan Medical Center
Target Recruit Count
199
Registration Number
NCT00841854
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders

First Posted Date
2009-01-27
Last Posted Date
2012-05-08
Lead Sponsor
Nycomed
Target Recruit Count
1045
Registration Number
NCT00830115
Locations
🇩🇪

Nycomed Deutschland GmbH, Zwickau, Germany

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy